Compare
Side-by-side next gates and Survive-to-Event — pick up to three tickers.
| Field | CAPR | SRPT |
|---|
| Name | Capricor Therapeutics | Sarepta Therapeutics |
| Next gate | 2026-08-22 · PDUFAConfirmed | 2026-11-15 · label expandCompany-guided |
| Survive-to-Event | ok | ok |
| Cash | $148M (2026-03-31) | $1.2B (2026-03-31) |
| Burn / mo | $9M | $45M |
| Lead phase | Filed | Approved |
| Indication | duchenne-md | duchenne-md |